Page last updated: 2024-11-05

vigabatrin and Sleep Apnea Syndromes

vigabatrin has been researched along with Sleep Apnea Syndromes in 1 studies

Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.

Research Excerpts

ExcerptRelevanceReference
"A case of a patient with medically intractable epilepsy, who developed obstructive sleep apnoea (OSA), and an increase in seizure frequency, as a consequence of weight gain following treatment with vigabatrin is described."7.69Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril). ( Bird, JM; Lambert, MV, 1997)
"A case of a patient with medically intractable epilepsy, who developed obstructive sleep apnoea (OSA), and an increase in seizure frequency, as a consequence of weight gain following treatment with vigabatrin is described."3.69Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril). ( Bird, JM; Lambert, MV, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lambert, MV1
Bird, JM1

Other Studies

1 other study available for vigabatrin and Sleep Apnea Syndromes

ArticleYear
Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril).
    Seizure, 1997, Volume: 6, Issue:3

    Topics: Adult; Anticonvulsants; Epilepsy; gamma-Aminobutyric Acid; Humans; Male; Seizures; Sleep Apnea Syndr

1997